Published in J Virol on October 01, 2006
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Quantifying T lymphocyte turnover. J Theor Biol (2013) 1.35
Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci (2006) 1.24
Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro. Vet Res (2013) 0.91
How the DNA damage response determines the fate of HTLV-1 Tax-expressing cells. Retrovirology (2012) 0.87
Rates of CTL killing in persistent viral infection in vivo. PLoS Comput Biol (2014) 0.87
Vaccination against δ-retroviruses: the bovine leukemia virus paradigm. Viruses (2014) 0.84
Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep. J Virol (2006) 0.83
Viral expression directs the fate of B cells in bovine leukemia virus-infected sheep. J Virol (2011) 0.81
Earlier onset of delta-retrovirus-induced leukemia after splenectomy. PLoS One (2009) 0.81
Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads. Retrovirology (2009) 0.78
Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors. Pathogens (2012) 0.75
The lymph-borne cells of the immune response. Q J Exp Physiol Cogn Med Sci (1963) 4.64
Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene (2005) 2.96
Population biology of lymphocytes: the flight for survival. Annu Rev Immunol (2000) 2.96
Chemokines in the systemic organization of immunity. Immunol Rev (2003) 2.25
Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem (2004) 2.04
In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69
Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods (1989) 1.66
Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst (2001) 1.64
The physiology of lymphocyte migration through the single lymph node in vivo. Semin Immunol (1999) 1.60
Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections. J Virol (1989) 1.42
A road less travelled: large animal models in immunological research. Nat Rev Immunol (2003) 1.42
Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene (2005) 1.38
Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene (2005) 1.32
Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci (2006) 1.24
Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses (2000) 1.16
Tracking of leukocyte recruitment into tissues of mice by in situ labeling of blood cells with the fluorescent dye CFDA SE. J Immunol Methods (2004) 1.10
Distinct recirculating and non-recirculating B-lymphocyte pools in the peripheral blood are defined by coordinated expression of CD21 and L-selectin. Blood (1997) 1.07
B-cell homeostasis, competition, resources, and positive selection by self-antigens. Immunol Rev (2004) 1.07
Rapid turnover of the recirculating lymphocyte pool in vivo. Int Immunol (1995) 1.05
Bovine leukemia virus induces CD5- B cell lymphoma in sheep despite temporarily increasing CD5+ B cells in asymptomatic stage. Virology (1994) 1.01
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci U S A (2002) 1.01
Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy. Cancer Res (2005) 0.99
A novel mechanism of CD4 lymphocyte depletion involves effects of HIV on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors. J Immunol (1999) 0.93
Tracking dendritic cells: use of an in situ method to label all blood leukocytes. Int Immunol (2003) 0.92
Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants. Retrovirology (2004) 0.92
Asymptomatic simian immunodeficiency virus infection decreases blood CD4(+) T cells by accumulating recirculating lymphocytes in the lymphoid tissues. J Virol (1999) 0.91
Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol (1999) 0.91
Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep. J Virol (1998) 0.91
Two B cell subpopulations have distinct recirculation characteristics. Eur J Immunol (1998) 0.89
Surface Ig on B lymphocytes from cattle and sheep. Int Immunol (1997) 0.88
Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle. J Virol (2003) 0.85
Pathogenesis and treatment of human T-cell leukemia virus infection. Immunol Res (2005) 0.84
Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1. Oncogene (2005) 0.82
Thymic export in aged sheep: a continuous role for the thymus throughout pre- and postnatal life. Eur J Immunol (2001) 0.81
Considerations on B cell homeostasis. Curr Top Microbiol Immunol (2000) 0.79
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med (2010) 3.20
The HTLV-1 Tax interactome. Retrovirology (2008) 2.02
Reduction of B cell turnover in chronic lymphocytic leukaemia. Br J Haematol (2008) 1.74
Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J Exp Med (2005) 1.72
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol Rev (2010) 1.70
Measurement and modeling of human T cell kinetics. Eur J Immunol (2003) 1.61
B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood (2005) 1.52
Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody. Proc Natl Acad Sci U S A (2012) 1.50
Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol (2002) 1.44
Elevated fat skatole levels in immunocastrated, surgically castrated and entire male pigs with acute dysentery. Vet J (2012) 1.37
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology (2007) 1.35
Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J Immunol (2010) 1.32
From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol (2010) 1.29
HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog (2010) 1.28
Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci (2006) 1.24
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol (2006) 1.22
Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis. Proc Natl Acad Sci U S A (2008) 1.18
Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol (2004) 1.17
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology (2012) 1.16
Migratory monocytes and granulocytes are major lymphatic carriers of Salmonella from tissue to draining lymph node. J Leukoc Biol (2005) 1.15
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses (2011) 1.14
Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci (2007) 1.13
New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases. Mol Cell Biol (2006) 1.11
Bluetongue virus targets conventional dendritic cells in skin lymph. J Virol (2009) 1.08
Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst (2003) 1.08
Characterization of dendritic cells subpopulations in skin and afferent lymph in the swine model. PLoS One (2011) 1.07
Class IIa histone deacetylases: conducting development and differentiation. Int J Dev Biol (2009) 1.07
Cervical duct cannulation in sheep for collection of afferent lymph dendritic cells from head tissues. Nat Protoc (2006) 1.04
Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J Virol (2002) 1.04
Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies. EuroIntervention (2010) 1.04
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis (2004) 1.04
Rapid turnover of T cells in acute infectious mononucleosis. Eur J Immunol (2003) 1.03
Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol (2008) 1.03
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog (2011) 1.02
Evaluation of tests for antibodies against bovine herpesvirus 1 performed in national reference laboratories in Europe. Vet Microbiol (2004) 1.02
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci U S A (2005) 1.02
Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clin Cancer Res (2009) 1.01
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci U S A (2002) 1.01
Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans. Blood (2013) 1.01
The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci (Landmark Ed) (2009) 1.00
In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis (2011) 1.00
MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX. Biochim Biophys Acta (2005) 1.00
T-cell epitope prediction: rescaling can mask biological variation between MHC molecules. PLoS Comput Biol (2009) 0.99
Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract. J Leukoc Biol (2004) 0.99
Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc Natl Acad Sci U S A (2004) 0.99
Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy. Cancer Res (2005) 0.99
The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol (2009) 0.99
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood (2007) 0.98
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Blood (2011) 0.98
Genetic and metabolic aspects of androstenone and skatole deposition in pig adipose tissue: a review. Genet Sel Evol (2007) 0.98
Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo. J Virol (2002) 0.98
Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood (2011) 0.97
Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog (2013) 0.97
HTLV-1: persistence and pathogenesis. Virology (2013) 0.97
Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J Virol (2002) 0.97
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol (2008) 0.97